RICHMOND, Calif., Sept. 18 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO - News) announced today that Edward Lanphier, Sangamo’s president and chief executive officer, will provide an overview of the company’s business strategy and an update on the progress of Sangamo’s therapeutic development programs on Monday, September 25, 2006 at 11:30 a.m. (ET) at the UBS Global Life Sciences Conference in New York.
